{"id":"W4290615255","doi":"10.1186/s13075-022-02877-9","title":"A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis","year":2022,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Infliximab; Placebo; Internal medicine; Ankylosing spondylitis; Adverse effect; Clinical endpoint; Rheumatology; Sulfasalazine; Randomized controlled trial; Surgery; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003244014,0.002670811,0.005818001,0.0007607025,0.001143305,0.001469863,0.001314658,0.00357344,0.007714028],"category_scores_gemma":[0.003446307,0.001332067,0.001712456,0.0006656712,0.002226534,0.001387147,0.0006049423,0.003457762,0.001642274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007778006,"about_ca_system_score_gemma":0.002087769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009321803,"about_ca_topic_score_gemma":0.002412725,"domain_scores_codex":[0.9980133,0.001053124,0.0001668083,0.0003451245,0.0001676514,0.000254006],"domain_scores_gemma":[0.9979327,0.0004845237,0.0004703479,0.0001683276,0.0002054902,0.0007386053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9871143,0.005933013,0.0002241757,0.0003370784,0.0002662584,0.00002043575,0.00003103066,0.0000794291,0.001461424,0.00003047683,0.0002285095,0.004273828],"study_design_scores_gemma":[0.9786819,0.0205792,0.0003909043,0.000009659102,0.00005835092,0.000007661856,0.00000422233,0.00006273378,0.00006557455,0.00001866653,0.0001167268,0.000004521318],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9697064,0.005503333,0.001302081,0.001107396,0.001644379,0.01673909,0.001404087,0.0002988256,0.002294411],"genre_scores_gemma":[0.9599003,0.003798005,0.003469531,0.002402379,0.001437315,0.02249834,0.001469683,0.00005278995,0.004971604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007714028,"threshold_uncertainty_score":0.02580601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05057344740237421,"score_gpt":0.3328261670797753,"score_spread":0.2822527196774011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}